NCT04270175 2026-02-27Daratumumab, Pomalidomide, and Dexamethasone (DPd) in Relapsed/Refractory Light Chain Amyloidosis Patients Previously Exposed to DaratumumabWeill Medical College of Cornell UniversityPhase 2 Active not recruiting15 enrolled